Intracranial Distribution of Intravenously Administered Gadolinium-Based Contrast Agent Over a Period of 24 Hours: Evaluation With 3d-Real IR Imaging and MR Fingerprinting

Magnetic Resonance in Medical Sciences - Japan
doi 10.2463/mrms.mp.2020-0030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society for Magnetic Resonance in Medicine

Related search

Gadolinium-Based Hybrid Nanoparticles as a Positive MR Contrast Agent

English

Spinal Epidural Abscess: Evaluation With Gadolinium-Enhanced MR Imaging.

Radiographics
MedicineNuclear MedicineRadiologyImaging
1993English

Quantification of Endolymphatic Space Volume After Intravenous Administration of a Single Dose of Gadolinium-Based Contrast Agent: 3d-Real Inversion Recovery Versus HYDROPS-Mi2

Magnetic Resonance in Medical Sciences
Nuclear MedicineRadiologyImaging
2019English

Non-Contrast Intracranial MR Venography With 3d-Phase Contrast Imaging : Optimization of Presaturation Pulse and Velocity Encoding : Report on the ECR2003(European Congress of Radiology)

Nippon Hoshasen Gijutsu Gakkai zasshi
Medicine
2003English

Microbial Growth in Neonatal Intravenous Fat Emulsion Administered Over 12 Versus 24 Hours

Journal of Pediatric Pharmacology and Therapeutics
Child HealthPediatricsPerinatologyPharmacology
2013English

3D Contrast Enhancement-Mr Angiography for Imaging of Unruptured Cerebral Aneurysms: A Hospital-Based Prevalence Study

PLoS ONE
Multidisciplinary
2014English

Feeding Induced by Intracranial and Intravenously Administered 2-Deoxy-D-Glucose

Physiological Psychology
1974English

MR Imaging Measures of Intracranial Atherosclerosis in a Population-Based Study

Radiology
Nuclear MedicineRadiologyImaging
2016English

A New Class of Smart Gadolinium Contrast Agent for Tissue pH Probing Using Magnetic Resonance Imaging

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy